Anti-TNF-α in the treatment of non-infectious uveitis

被引:3
|
作者
Hoogewoud, Florence [1 ,2 ]
Kowalczuk, Laura [2 ,3 ]
Bousquet, Elodie [1 ,3 ]
Brezin, Antoine [1 ,3 ]
Touchard, Elodie [4 ]
Buggage, Ronald [4 ]
Bordet, Thierry [4 ]
Behar-Cohen, Francine [1 ,3 ]
机构
[1] Univ Paris, Ophtalmopole Hop Cochin, Assistance Publ Fopitaux Paris, 27 Rue Faubourg St Jacques, F-75014 Paris, France
[2] Univ Lausanne, Dept Ophtalmol, Hop Ophtalmol Jules Gonin, Lausanne, Switzerland
[3] Univ Paris, Inserm UMR 1138, Physiopathol Malad Oculaires Innovat Therapeut, Ctr Rech Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France
[4] Eyevensys SAS, Paris, France
来源
M S-MEDECINE SCIENCES | 2020年 / 36卷 / 10期
关键词
TUMOR-NECROSIS-FACTOR; LONG-TERM EFFICACY; ANTERIOR UVEITIS; ELECTROTRANSFER; ADALIMUMAB; INFLIXIMAB; DELIVERY; PRINCIPLES; THERAPY; FLARES;
D O I
10.1051/medsci/2020160
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-infectious uveitis is a heterogenous group of potentially blinding ocular autoimmune diseases that may represent a manifestation of a systemic condition or may affect the eyes only. A systemically administered anti-TNF has recently been approved for the treatment of non-infectious uveitis, broadening the therapeutic arsenal available to control intraocular inflammation and reduce uveitis complications that can lead to vision loss. When uveitis affects only the eyes, a local anti-TNF-alpha administration strategy could optimize the ocular therapeutic effect and reduce undesirable systemic side-effects. A new ocular method of non-viral gene therapy, currently in development, may broaden the indications for ocular anti-TNF-alpha agents, not only for uveitis but also for other diseases in which TNF-alpha-mediated neuro-inflammation has been demonstrated.
引用
收藏
页码:893 / 899
页数:7
相关论文
共 50 条
  • [41] Adalimumab treatment in adult patients with refractory non-infectious uveitis
    Esen, Ebru
    Isik, Puren
    Sizmaz, Selcuk
    Demircan, Nihal
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 457 - 462
  • [42] Intravitreal dexamethasone implant results in the treatment of non-infectious uveitis
    Dikmen, Nejla Tukenmez
    Vural, Ece Turan
    Yenerel, Nursal Melda
    Dikkaya, Funda
    Elibol, Emine Savran
    Kockar, Alev
    NORTHERN CLINICS OF ISTANBUL, 2022, 9 (06) : 638 - 645
  • [43] Rituximab for non-infectious Uveitis and Scleritis
    Caleb C. Ng
    Aileen Sy
    Emmett T. Cunningham
    Journal of Ophthalmic Inflammation and Infection, 11
  • [44] Tocilizumab in adult non-infectious uveitis
    Lo, Tiffany
    Rogers, Sophie
    Ross, Laura
    Bosco, Julian
    Lim, Lyndell
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [45] Immunomodulatory Therapy for non-infectious Uveitis
    Heinz, C.
    OPHTHALMOLOGE, 2019, 116 (10): : 917 - 917
  • [46] Adalimumab for the Treatment of Non-Infectious Uveitis: A Real Life Experience
    Raad, Fatima
    Luque, Paula
    Ledo, Sofia Garcia
    Lozano, Alicia Alda
    Llorens, Victor
    Espejo, Antonio
    Heras, Henar
    Santana, Lucia
    Trapiella, Luis
    Fanlo, Patricia
    Adan, Alfredo
    Espinosa, Gerard
    Navarrete, Nuria
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2024,
  • [47] Non-infectious systemic diseases and uveitis
    Diaz-Valle, D.
    Mendez, R.
    Arriola, P.
    Cuina, R.
    Arino, M.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2008, 31 : 97 - 110
  • [48] Systemic Corticosteroids in Non-infectious Uveitis
    Ness, Thomas
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2018, 235 (05) : 592 - 596
  • [49] EYS606 for the Treatment of Non-Infectious Uveitis (NIU)
    Buggage, Ronald
    Behar-Cohen, Francine F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [50] Long-term treatment with Tocilizumab for non-infectious uveitis
    Mesquida, Marina
    Molins, Blanca
    Llorens, Victor
    Sala-Puigdollers, Anna
    Matas, Jessica
    Zarranz-Ventura, Javier
    Sainz De La Maza, Maite
    Adan Civera, Alfredo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)